Lorbrena Now Approved Sites
Brand: Lorbrena (lorlatinib), Tablets
Parent Company: Pfizer
Drug Type: Prescription
Drug Category: Oncology
Campaign: now-approved
Targeting: HCPs, Patients, Caregivers
Patient Website: https://www.lorbrena.com/
HCP Website: https://www.lorbrenahcp.com/